A Phase I Study of Quadrivalent Human Papilloma Virus (HPV) (Types 6, 11, 16, 18) Recombinant Vaccine in HIV-Infected and HIV-Negative Pre-Adolescents, Adolescents, and Young Adults

NCT00798265 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

26

Enrollment

NIH

Sponsor class

Stopped Study closed due to low accrual.

Conditions

Human Immunodeficiency Virus
Human Papillomavirus- 6, 11, 16, 18
Adolescent
Papillomavirus Vaccines

Interventions

BIOLOGICAL: Gardasil
BEHAVIORAL: Survey

Sponsor

National Cancer Institute (NCI)